BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30850940)

  • 1. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients.
    Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G
    Metab Brain Dis; 2019 Jun; 34(3):715-720. PubMed ID: 30850940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of Huntington's Disease Phenotype by Genistein-Induced Autophagy in the Cellular Model.
    Pierzynowska K; Gaffke L; Hać A; Mantej J; Niedziałek N; Brokowska J; Węgrzyn G
    Neuromolecular Med; 2018 Mar; 20(1):112-123. PubMed ID: 29435951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation.
    Pierzynowska K; Podlacha M; Gaffke L; Rintz E; Wiśniewska K; Cyske Z; Węgrzyn G
    Autophagy; 2024 May; 20(5):1159-1182. PubMed ID: 37992314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
    Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
    Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
    Liu Y; Hettinger CL; Zhang D; Rezvani K; Wang X; Wang H
    J Neurochem; 2014 May; 129(3):539-47. PubMed ID: 24383989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease.
    Lobato AG; Ortiz-Vega N; Zhu Y; Neupane D; Meier KK; Zhai RG
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166928. PubMed ID: 38660915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington's disease by lowering mutant huntingtin protein.
    Sun X; Zhu J; Sun XY; Ji M; Yu XL; Liu RT
    Food Funct; 2020 Feb; 11(2):1334-1348. PubMed ID: 32043503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition.
    Fernandez-Estevez MA; Casarejos MJ; López Sendon J; Garcia Caldentey J; Ruiz C; Gomez A; Perucho J; de Yebenes JG; Mena MA
    PLoS One; 2014; 9(2):e90202. PubMed ID: 24587280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.
    Ceccarelli I; Fiengo P; Remelli R; Miragliotta V; Rossini L; Biotti I; Cappelli A; Petricca L; La Rosa S; Caricasole A; Pollio G; Scali C
    Neurobiol Dis; 2016 Feb; 86():41-51. PubMed ID: 26626080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making (anti-) sense out of huntingtin levels in Huntington disease.
    Evers MM; Schut MH; Pepers BA; Atalar M; van Belzen MJ; Faull RL; Roos RA; van Roon-Mom WM
    Mol Neurodegener; 2015 Apr; 10():21. PubMed ID: 25928884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-to-mouse prion-like propagation of mutant huntingtin protein.
    Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
    Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
    Fu Y; Sun X; Lu B
    Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.